Neoadjuvant immunotherapy for melanoma is now ready for clinical practice - Nature Medicine

Norge Nyheter Nyheter

Neoadjuvant immunotherapy for melanoma is now ready for clinical practice - Nature Medicine
Norge Siste Nytt,Norge Overskrifter
  • 📰 NatureMedicine
  • ⏱ Reading Time:
  • 15 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 53%

Neoadjuvant immunotherapy for melanoma is now ready for clinical practice. Comment from Claus Garbe uni_tue, Reinhard Dummer UZH_ch and colleagues.

C.G. declares funding from and has an advisory role at Merck Sharp & Dhome , Novartis, NeraCare, Bristol-Meyers Squibb and Philogen. R.D. has an advisory role at Novartis, MSD, BMS, Roche, Amgen, Takeda, Pierre Fabre, Sun Pharma, Sanofi, Catalym, Second Genome, Regeneron, Alligator, T3 Pharma, MaxiVAX SA, Pfizer and touchIME. T.A. has an advisory role at CeCaVa, Novartis, NeraCare, BMS, Pierre Fabre, Sanofi, SkylineDx and iFIT. R.A. declares funding from Novartis. P.A.

has an advisory role at BMS, MSD, Novartis, Roche, Pierre-Fabre and QBiotics. O.M. has an advisory role at BMS, Roche-Genentech, MSD, Novartis, Merck Serono, Pierre Fabre, AstraZeneca and Immunocore. P.N. has an advisory role at MSD, Novartis, Merck, BMS, Pfizer, Immunocore and Ipsen. S.P.

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

NatureMedicine /  🏆 451. in US

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

Personalized antisense oligonucleotides ‘for free, for life’ — the n-Lorem Foundation - Nature MedicinePersonalized antisense oligonucleotides ‘for free, for life’ — the n-Lorem Foundation - Nature MedicinePersonalized antisense oligonucleotides ‘for free, for life’ — the n-Lorem Foundation. Correspondence from jogleeson_ucsd DrStanleyCrooke and colleagues n_lorem
Les mer »

Resilience to autosomal dominant Alzheimer’s disease in a Reelin-COLBOS heterozygous man - Nature MedicineResilience to autosomal dominant Alzheimer’s disease in a Reelin-COLBOS heterozygous man - Nature MedicineCase report of an individual heterozygous for a rare RELN-COLBOS variant that confers resilience, via a gain-of-function mechanism, to Alzheimer’s disease. ytquiroz DrJoeArboleda diegosflab
Les mer »

CDC Warning: The Eye Drop Danger Lurking in Your Medicine CabinetCDC Warning: The Eye Drop Danger Lurking in Your Medicine CabinetThe CDC warned against using EzriCare eye drops after they were linked to drug-resistant bacterial infections, vision loss, and death. Researchers have now detailed a case of a corneal ulcer caused by Pseudomonas aeruginosa, which was traced back to contaminated eye drops. Although the product has b
Les mer »

Adolescent medicine doctors out at Dell Children's amid Paxton probe of gender-affirming careAdolescent medicine doctors out at Dell Children's amid Paxton probe of gender-affirming careAll doctors staffing Dell Children’s adolescent medicine clinic are departing after Texas Attorney General Ken Paxton announced an investigation into whether gender-affirming care procedures were “unlawfully performed on minor children” at the hospital.
Les mer »

Expert Perspectives on the Potential Capabilities and Pitfalls for AI-Based Language Tools in MedicineExpert Perspectives on the Potential Capabilities and Pitfalls for AI-Based Language Tools in Medicine❓ Are you aware of the latest information regarding AI tools in medicine? Learn from experts on the pros and cons of AI in medicine. MedEd 📍 Click here to learn:
Les mer »

‘Will I die if I don’t get my medicine’ – Congress examines drug shortages‘Will I die if I don’t get my medicine’ – Congress examines drug shortagesPeople can’t get the medications they need to survive or live healthier lives because of drug shortages.
Les mer »



Render Time: 2025-03-09 23:33:04